当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
The New England Journal of Medicine ( IF 158.5 ) Pub Date : 2022-11-07 , DOI: 10.1056/nejmoa2213169 Mason W Freeman 1 , Yuan-Di Halvorsen 1 , William Marshall 1 , Mackenzie Pater 1 , Jon Isaacsohn 1 , Catherine Pearce 1 , Brian Murphy 1 , Nicholas Alp 1 , Ajay Srivastava 1 , Deepak L Bhatt 1 , Morris J Brown 1 ,
The New England Journal of Medicine ( IF 158.5 ) Pub Date : 2022-11-07 , DOI: 10.1056/nejmoa2213169 Mason W Freeman 1 , Yuan-Di Halvorsen 1 , William Marshall 1 , Mackenzie Pater 1 , Jon Isaacsohn 1 , Catherine Pearce 1 , Brian Murphy 1 , Nicholas Alp 1 , Ajay Srivastava 1 , Deepak L Bhatt 1 , Morris J Brown 1 ,
Affiliation
New England Journal of Medicine, Ahead of Print.
中文翻译：
Baxdrostat 治疗难治性高血压的 2 期试验
新英格兰医学杂志，印刷前。
更新日期：2022-11-08
中文翻译：
Baxdrostat 治疗难治性高血压的 2 期试验
新英格兰医学杂志，印刷前。
京公网安备 11010802027423号